 | Up a level |
Quteineh, L; Bochud, P-Y; Golshayan, D; Crettol, S; Venetz, J-P; Manuel, O; Kutalik, Z; Treyer, A; Lehmann, R; Mueller, N J; Binet, I; van Delden, C; Steiger, J; Mohacsi, P; Dufour, Jean-François; Soccal, P M; Pascual, M; Semmo, Nasser; Beldi, Guido and Eap, C B (2015). CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics journal, 17(1), pp. 69-75. Nature Publishing Group 10.1038/tpj.2015.82
Carrel, T; Englberger, L; Martinelli, M V; Takala, J; Boesch, C; Sigurdadottir, V; Gygax, E; Kadner, A; Mohacsi, P (2012). Continuous flow left ventricular assist devices: a valid option for heart failure patients. Swiss medical weekly, 142, w13701. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2012.13701
Baur, B; Oroszlan, M; Hess, O; Carrel, T; Mohacsi, P (2011). Efficacy and safety of sirolimus and everolimus in heart transplant patients: a retrospective analysis. Transplantation proceedings, 43(5), pp. 1853-61. New York, N.Y.: Elsevier 10.1016/j.transproceed.2011.01.174
Bösch, C; Mohacsi, P (2011). Wechselbeziehungen bei Herzinsuffizienz: Der Teufelskreis zwischen Herz und Nieren. Hausarztpraxis - Fortschritte der Medizin, 3(10-13) Zürich: Prime Public Media AG
Epailly, E; Albanell, J; Andreassen, A; Bara, C; Campistol, J; Delgado, J; Eisen, H; Fiane, A; Mohacsi, P; Schubert, S; Sebbag, L; Turazza, F; Valantine, H; Zuckermann, A; Potena, L (2011). Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions. Clinical transplantation, 25(5), E475-E486. Oxford: Wiley-Blackwell 10.1111/j.1399-0012.2011.01476.x
Martinelli, M; Bösch, C; Signorell, J; Mohacsi, P (2011). Chronische Herzinsuffizienz im fortgeschrittenen Stadium – konservativ medikamentöse Therapie, Kunstherz- oder Herztransplantation? Therapeutische Umschau, 68, pp. 715-23. Bern: Huber
Mohacsi, P (2011). Die Herzleistungsschwäche ist des Teufels. Hausarztpraxis - Fortschritte der Medizin, 3, p. 5. Zürich: Prime Public Media AG
Mohacsi, P (2011). Herzinsuffizienz – Interaktion eines zentralen Organs mit den Nieren, den Lungen und der Leber. Cardiovasc, 10(5), p. 1. Prime Public Media AG
Zweifel, M; Matozan, K; Dahinden, C; Schaffner, T; Mohacsi, P (2010). Eotaxin/CCL11 levels correlate with myocardial fibrosis and mast cell density in native and transplanted rat hearts. Transplantation proceedings, 42(7), pp. 2763-6. New York, N.Y.: Elsevier 10.1016/j.transproceed.2010.05.152
Schmid, JP; Blatter-Bühler, P; Gaillet, R; Binder, RK; Walker Schmid, R; Mohacsi, P; Saner, H (2010). Impact of a cardiac rehabilitation programme on exercise capacity, parameters of left ventricular function and health related quality of life in chronic heart failure patients: Results from a prospective single centre cohort. Cardiovascular medicine, 13, pp. 86-91. Basel: EMH Swiss Medical Publishers Ltd
Roten, Laurent; Schmid, J-P; Merz, F; Carrel, T; Zwahlen, M; Walpoth, N; Mohacsi, P; Hullin, R (2009). Diastolic dysfunction of the cardiac allograft and maximal exercise capacity. Journal of heart and lung transplantation, 28(5), pp. 434-439. New York, N.Y.: Elsevier 10.1016/j.healun.2008.12.001
Tanner, H; Mohacsi, P; Fuller-Bicer, G A; Rieben, R; Meier, B; Hess, O; Hullin, R (2007). Cytokine activation and disease progression in patients with stable moderate chronic heart failure. Journal of heart and lung transplantation, 26(6), pp. 622-9. New York, N.Y.: Elsevier 10.1016/j.healun.2007.01.033
Banz Wälti, Yara; Rieben, R; Inderbitzin, D; Seiler, C; Schmid, S; Dufour, Jean-François; Smith, R; Nydegger, U; Zimmermann, A; Mohacsi, P; Candinas, Daniel (2007). Immunological preconditioning, including local complement inhibition, in ABO-incompatible auxiliary partial orthotopic liver transplantation as a bridge to definitive grafting in hyperacute liver failure: First report of a successful strategy. Molecular immunology, 44(1-3), pp. 153-154. Amsterdam: Elsevier 10.1016/j.molimm.2006.07.020
Metra, M; Ponikowski, P; Dickstein, K; McMurray, JJ; Gavazzi, A; Bergh, CH; Fraser, AG; Jaarsma, T; Pitsis, A; Mohacsi, P; Böhm, M; Anker, S; Dargie, H; Brutsaert, D; Komajda, M; Heart, Failure Association of the European Society of Cardiology (2007). Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. European journal of heart failure, 9(6-7), pp. 684-94. Oxford: Oxford University Press 10.1016/j.ejheart.2007.04.003
Stüdeli, R; Jung, S; Mohacsi, P; Perruchoud, S; Castiglioni, P; Wenaweser, P; Heimbeck, G; Feller, M; Hullin, R (2006). Diastolic dysfunction in human cardiac allografts is related with reduced SERCA2a gene expression. American journal of transplantation, 6(4), pp. 775-82. Oxford: Wiley-Blackwell 10.1111/j.1600-6143.2006.01241.x
von Scheidt, W; Costard-Jaeckle, A; Stempfle, HU; Deng, MC; Schwaab, B; Haaff, B; Naegele, H; Mohacsi, P; Trautnitz, M; PROPHET, Study Group (2006). Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study. Journal of heart and lung transplantation, 25(9), pp. 1070-6. New York, N.Y.: Elsevier 10.1016/j.healun.2006.04.011
Krum, H; Mohacsi, P; Katus, HA; Tendera, M; Rouleau, JL; Fowler, MB; Coats, AJ; Roecker, EB; Packer, M; Carvedilol, Prospective Randomized Cumulative Survival (COPERNICUS) Study Gr (2006). Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study. American Heart Journal, 151(1), pp. 55-61. St. Louis, Mo.: Elsevier 10.1016/j.ahj.2005.03.054
Buser, P; Brunner-La, Rocca HP; Leventhal, M; Mahrer, R; Mohacsi, P; Nuesch, K; Périat, P; Seydoux, C; Stöhr, S (2006). Empfehlungen zur vernetzten Betreuung der Herzinsuffizienzpatienten in der Schweiz. Schweizerische Ärztezeitung, 45(87), pp. 1943-1952. Basel: EMH Schweizerischer Ärzteverlag AG
Nydegger, U E; Rieben, R; Carrel, T; Mohacsi, P (2004). Solid organ transplantation across the ABO histo-blood group barrier: a case report. Transplantation proceedings, 36(5), pp. 1554-7. New York, N.Y.: Elsevier 10.1016/j.transproceed.2004.05.038
